69 results
Page 3 of 4
8-K
bncohs4lx
15 Jul 21
Other Events
12:00am
8-K
EX-99.1
8iruinuvp 0amawf
13 Oct 20
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
6:10am
8-K
EX-99.1
9kra7ov
23 Apr 20
Avenue Therapeutics Announces Presentation of IV Tramadol E-Posters
9:00am
8-K
EX-99.1
y2ocx mtic
30 Mar 20
Avenue Therapeutics Reports Full Year 2019 Financial Results and Recent Corporate Highlights
9:01am
8-K
EX-99.1
uox171tptfkl
14 Aug 19
Avenue Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
12:00am
8-K
EX-99.1
57tmqa
3 Jun 19
Avenue Therapeutics Announces Positive Topline Data from Second Pivotal Phase 3 Study of Intravenous Tramadol in the Management of Postoperative Pain
8:45am
8-K
EX-99.1
oy6fvruhbaneg2p httn
25 May 18
Regulation FD Disclosure
8:30am
8-K
EX-99.1
0ekspf
21 May 18
Avenue Therapeutics Announces Positive Topline Phase 3 Data for Intravenous Tramadol in the Management of Postoperative Pain
8:15am
8-K
EX-99.1
w60u ov3p0ws41zd
3 May 18
Avenue Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
8:00am
10-K
bygxv
1 Mar 18
Annual report
12:00am